focus -WSS

focus

author：entertainment 2025-10-01 02:14:18 - browse：76629

Senate Finance Committee Chair Ron Wyden (D-Ore.) Leah Millis/Pool via AP

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies.

The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a drug’s price.

“It’s pretty hard to get 26 votes around here,” Finance Chair Ron Wyden (D-Ore.) said after the vote. “So we’re thrilled.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： What a koala virus tells us about the human genome

WSS

New Covid vaccine is recommended for everyone 6 months or older

As H5N1 spreads in cows, experts warn against drinking raw milk

WuXi Biologics beefs up its lobbying operation

Pig kidney works a record two months in donated body

How medical schools plan to diversify without affirmative action

FDA panel endorses Alnylam’s heart drug — after picking it apart

focus

focus

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

HHS suspends federal funding for EcoHealth Alliance

Medicare proposal to cover medical devices draws a mixed reaction

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Apple is now the first public company to be valued at $3 trillion

Lilly’s weekly insulin works as well as daily products, new studies show

Drug repurposing or repositioning? The language matters

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Sports medicine is finally prioritizing gender equality

Free medical tuition alone isn't enough to close gaps in primary care

focus

ALS treatment from Biogen, Ionis fails in study

WATCH: Why do bright lights make us see spots?

Abbott's new stent may help patients with peripheral artery disease

Popular nasal decongestant doesn't actually relieve congestion

HHS suspends federal funding for EcoHealth Alliance

Regeneron agrees to White House price limits on anti

explore

hotspot

Wikipedia

entertainment